<!doctype html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <title>BioNova Clinical Trials Graph</title>
    <meta
      name="description"
      content="Twenty-two clinical trial MedicalTrial items with drug, medical organization, investigator, and framework links. Includes multi-phase progression path helper."
    />
  </head>
  <body>
    <header>
      <h1>BioNova Clinical Trials Graph</h1>
      <p>
        This file enumerates 22 clinical trial items spanning all major drugs,
        phases, and trial sites. Each trial links to its drug, medical
        organization, principal investigator, and compliance frameworks. Rich
        descriptions and explicit relationships support both vector and graph
        evaluation scenarios.
      </p>
    </header>

    <section>
      <h2>Clinical Trials</h2>
      <!-- Example trial: Oncora Phase III -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/oncora-phase-iii"
      >
        <h3 itemprop="name">Oncora Phase III Efficacy Study</h3>
        <p itemprop="description">
          Randomized, double-blind, multicenter trial evaluating Oncora's
          efficacy and safety in advanced solid tumor patients. Primary
          endpoint: progression-free survival. Enrollment: 420. Start:
          2024-01-15. End: 2025-09-30.
        </p>
        <meta itemprop="identifier" content="TRIAL-ONCORA-III" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/oncora"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/eastern-oncology-center"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/global-phaseiii-consortium"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/asclepius"
            >Dr. Asclepius</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>

      <!-- Oncora-XR Preclinical Release -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/oncora-xr-preclinical-release"
      >
        <h3 itemprop="name">Oncora-XR Preclinical Release Study</h3>
        <p itemprop="description">
          Preclinical safety and pharmacokinetics study of Oncora-XR in murine
          and canine models. Focus: dose proportionality, tissue distribution,
          and early toxicity signals. Enrollment: 60. Start: 2023-03-01. End:
          2023-09-15.
        </p>
        <meta itemprop="identifier" content="TRIAL-ONCORA-XR-PRECLIN" />
        <meta itemprop="status" content="Completed" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/oncora-xr"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/oncology-trial-site-a"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/athena"
            >Dr. Athena</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>

      <!-- Cardiozen Phase III -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/cardiozen-phase-iii"
      >
        <h3 itemprop="name">Cardiozen Phase III Cardiovascular Outcomes</h3>
        <p itemprop="description">
          Multinational, placebo-controlled trial assessing Cardiozen's impact
          on major adverse cardiovascular events in high-risk patients.
          Enrollment: 800. Start: 2024-05-10. End: 2026-02-28.
        </p>
        <meta itemprop="identifier" content="TRIAL-CARDIOZEN-III" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/cardiozen"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/northern-cardiology-institute"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/global-phaseiii-consortium"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/hippocrates"
            >Dr. Hippocrates</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>

      <!-- Immunex Phase II -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/immunex-phase-ii"
      >
        <h3 itemprop="name">Immunex Phase II Autoimmune Biomarker Study</h3>
        <p itemprop="description">
          Phase II trial evaluating Immunex's efficacy in autoimmune biomarker
          modulation. Primary endpoint: reduction in ANA titers. Enrollment:
          150. Start: 2023-11-01. End: 2024-10-15.
        </p>
        <meta itemprop="identifier" content="TRIAL-IMMUNEX-II" />
        <meta itemprop="status" content="Completed" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/immunex"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/western-immunology-clinic"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/panacea"
            >Dr. Panacea</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>

      <!-- Immunex-Plus Preclinical Safety -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/immunex-plus-preclinical-safety"
      >
        <h3 itemprop="name">Immunex-Plus Preclinical Safety Study</h3>
        <p itemprop="description">
          Toxicology and safety assessment of Immunex-Plus in rodent and primate
          models. Focus: immunogenicity, cytokine release, and off-target
          effects. Enrollment: 40. Start: 2023-06-01. End: 2023-12-01.
        </p>
        <meta itemprop="identifier" content="TRIAL-IMMUNEX-PLUS-PRECLIN" />
        <meta itemprop="status" content="Completed" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/immunex-plus"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/immunology-trial-site-a"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/meditrina"
            >Dr. Meditrina</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>

      <!-- Neurova Phase I -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/neurova-phase-i"
      >
        <h3 itemprop="name">Neurova Phase I Dose Escalation</h3>
        <p itemprop="description">
          First-in-human, open-label, dose-escalation study of Neurova in
          healthy volunteers. Primary endpoint: maximum tolerated dose.
          Enrollment: 32. Start: 2024-02-01. End: 2024-07-15.
        </p>
        <meta itemprop="identifier" content="TRIAL-NEUROVA-I" />
        <meta itemprop="status" content="Completed" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/neurova"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/central-neuroscience-institute"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/chiron"
            >Dr. Chiron</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>

      <!-- Vitalis Postmarketing Study -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/vitalis-postmarketing-study"
      >
        <h3 itemprop="name">Vitalis Postmarketing Real-World Evidence Study</h3>
        <p itemprop="description">
          Observational study collecting real-world safety and effectiveness
          data for Vitalis in diverse patient populations. Enrollment: 1200.
          Start: 2025-01-01. End: 2027-06-30.
        </p>
        <meta itemprop="identifier" content="TRIAL-VITALIS-POSTMARKET" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/vitalis"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/postmarketing-registry-network"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/anchiale"
            >Dr. Anchiale</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>
      <!-- Expanded additional trials (11 total to reach 18) -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/oncora-dose-optimization"
      >
        <h3 itemprop="name">Oncora Phase II Dose Optimization Study</h3>
        <p itemprop="description">
          Adaptive, open-label trial refining Oncora dosing through
          pharmacokinetic and pharmacodynamic modeling. Enrollment: 180. Start:
          2023-06-01. End: 2024-04-30.
        </p>
        <meta itemprop="identifier" content="TRIAL-ONCORA-DOSE-OPT" />
        <meta itemprop="status" content="Completed" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/oncora"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/eastern-oncology-center"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/chronos"
            >Dr. Chronos</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/cardiozen-dose-ranging"
      >
        <h3 itemprop="name">Cardiozen Phase II Dose Ranging Study</h3>
        <p itemprop="description">
          Randomized, controlled dose-ranging trial assessing Cardiozen
          hemodynamic responses across four titration arms. Enrollment: 260.
          Start: 2023-12-01. End: 2024-11-20.
        </p>
        <meta itemprop="identifier" content="TRIAL-CARDIOZEN-DOSE" />
        <meta itemprop="status" content="Active, not recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/cardiozen"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/northern-cardiology-institute"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/ares"
            >Dr. Ares</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/immunex-biomarker-extension"
      >
        <h3 itemprop="name">Immunex Biomarker Extension Study</h3>
        <p itemprop="description">
          Extension cohort analyzing sustained autoimmune biomarker modulation
          after initial Immunex Phase II endpoints. Enrollment: 90. Start:
          2024-11-01. End: 2025-07-31.
        </p>
        <meta itemprop="identifier" content="TRIAL-IMMUNEX-EXT" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/immunex"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/western-immunology-clinic"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/hygieia"
            >Dr. Hygieia</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/immunex-plus-dosing-strategy"
      >
        <h3 itemprop="name">Immunex-Plus Dosing Strategy Optimization Study</h3>
        <p itemprop="description">
          Preclinical to early translational bridging study establishing
          combination dosing windows for Immunex-Plus components. Enrollment:
          55. Start: 2024-02-01. End: 2024-09-30.
        </p>
        <meta itemprop="identifier" content="TRIAL-IMMUNEX-PLUS-DOSING" />
        <meta itemprop="status" content="Completed" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/immunex-plus"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/immunology-trial-site-b"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/coeus"
            >Dr. Coeus</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/neurova-cognitive-biomarker"
      >
        <h3 itemprop="name">Neurova Cognitive Biomarker Validation Study</h3>
        <p itemprop="description">
          Phase Ib exploratory cohort validating digital cognitive endpoints and
          CSF biomarkers for Neurova future efficacy trials. Enrollment: 48.
          Start: 2024-08-01. End: 2025-03-15.
        </p>
        <meta itemprop="identifier" content="TRIAL-NEUROVA-COG" />
        <meta itemprop="status" content="Active, not recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/neurova"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/central-neuroscience-institute"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/chiron"
            >Dr. Chiron</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/vitalis-rare-disease-registry"
      >
        <h3 itemprop="name">Vitalis Rare Disease Global Registry</h3>
        <p itemprop="description">
          Prospective observational registry tracking metabolic correction and
          safety in global rare disease populations receiving Vitalis.
          Enrollment: 1600. Start: 2025-03-01. End: 2028-12-31.
        </p>
        <meta itemprop="identifier" content="TRIAL-VITALIS-REGISTRY" />
        <meta itemprop="status" content="Not yet recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/vitalis"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/global-rare-disease-network"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/ananke"
            >Dr. Ananke</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/oncora-xr-steady-state"
      >
        <h3 itemprop="name">Oncora-XR Steady-State Exposure Study</h3>
        <p itemprop="description">
          Single and multiple dose pharmacokinetic profiling for Oncora-XR to
          characterize steady-state plasma levels. Enrollment: 72. Start:
          2024-05-15. End: 2025-01-30.
        </p>
        <meta itemprop="identifier" content="TRIAL-ONCORA-XR-STEADY" />
        <meta itemprop="status" content="Active, not recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/oncora-xr"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/oncology-trial-site-b"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/selene"
            >Dr. Selene</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/immunex-pharmacodynamic-correlation"
      >
        <h3 itemprop="name">Immunex Pharmacodynamic Correlation Study</h3>
        <p itemprop="description">
          Phase II substudy correlating Immunex plasma levels with specific
          cytokine suppression trajectories. Enrollment: 110. Start: 2024-01-10.
          End: 2024-12-20.
        </p>
        <meta itemprop="identifier" content="TRIAL-IMMUNEX-PD" />
        <meta itemprop="status" content="Active, not recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/immunex"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/immunology-trial-site-c"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/dike"
            >Dr. Dike</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/cardiozen-quality-of-life"
      >
        <h3 itemprop="name">Cardiozen Quality of Life Outcomes Study</h3>
        <p itemprop="description">
          Prospective assessment of patient-reported functional status
          improvements under Cardiozen therapy. Enrollment: 300. Start:
          2024-03-01. End: 2025-06-30.
        </p>
        <meta itemprop="identifier" content="TRIAL-CARDIOZEN-QOL" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/cardiozen"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/northern-cardiology-institute"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/salus"
            >Dr. Salus</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/neurova-drug-drug-interaction"
      >
        <h3 itemprop="name">Neurova Drug-Drug Interaction Phase I Substudy</h3>
        <p itemprop="description">
          Evaluates Neurova interaction potential with standard-of-care agents
          via cytochrome modulation and cognitive performance comparisons.
          Enrollment: 36. Start: 2024-06-01. End: 2024-12-15.
        </p>
        <meta itemprop="identifier" content="TRIAL-NEUROVA-DDI" />
        <meta itemprop="status" content="Active, not recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/neurova"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/central-neuroscience-institute"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/nyx"
            >Dr. Nyx</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/vitalis-long-term-safety"
      >
        <h3 itemprop="name">Vitalis Long-Term Safety Follow-Up Study</h3>
        <p itemprop="description">
          Extended observation study tracking chronic safety events and
          metabolic stability over multiple years of Vitalis therapy.
          Enrollment: 900. Start: 2025-05-01. End: 2030-04-30.
        </p>
        <meta itemprop="identifier" content="TRIAL-VITALIS-LT" />
        <meta itemprop="status" content="Not yet recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/vitalis"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/global-rare-disease-network"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/panacea"
            >Dr. Panacea</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>
      <!-- Additional trials to complete the metadata coverage -->
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/phase2-oncology"
      >
        <h3 itemprop="name">Phase 2 Oncology Trial</h3>
        <p itemprop="description">
          Multi-arm, randomized Phase II trial evaluating novel therapeutic
          combinations in refractory solid tumors. Primary endpoint: objective
          response rate by RECIST criteria. Enrollment: 200. Start: 2023-09-01.
          End: 2024-12-31.
        </p>
        <meta itemprop="identifier" content="TRIAL-PHASE2-ONCO" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/oncora"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/eastern-oncology-center"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/oncology-trial-site-a"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/asclepius"
            >Dr. Asclepius</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/cardiozen-cardiologist-feedback"
      >
        <h3 itemprop="name">Cardiozen Cardiologist Feedback Survey Study</h3>
        <p itemprop="description">
          Qualitative study collecting structured feedback from practicing
          cardiologists on Cardiozen dosing, patient selection criteria, and
          real-world effectiveness observations. Enrollment: 150 cardiologists.
          Start: 2024-06-01. End: 2025-03-31.
        </p>
        <meta itemprop="identifier" content="TRIAL-CARDIOZEN-FEEDBACK" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/cardiozen"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/northern-cardiology-institute"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/hippocrates"
            >Dr. Hippocrates</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/immunex-autoimmune-biomarkers"
      >
        <h3 itemprop="name">Immunex Autoimmune Biomarker Discovery Study</h3>
        <p itemprop="description">
          Exploratory Phase IIa study identifying novel autoimmune biomarkers
          modulated by Immunex therapy through comprehensive proteomics and
          transcriptomics profiling. Enrollment: 80. Start: 2024-03-01. End:
          2025-01-15.
        </p>
        <meta itemprop="identifier" content="TRIAL-IMMUNEX-BIOMARKERS" />
        <meta itemprop="status" content="Active, not recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/immunex"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/western-immunology-clinic"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/immunology-trial-site-a"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/panacea"
            >Dr. Panacea</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/fda-compliance"
        />
      </article>
      <article
        itemscope
        itemtype="https://schema.org/MedicalTrial"
        itemid="https://bionova.example/id/trial/neurova-neurodegeneration-biomarkers"
      >
        <h3 itemprop="name">Neurova Neurodegeneration Biomarker Validation</h3>
        <p itemprop="description">
          Phase Ib/IIa biomarker-driven study validating fluid and imaging
          biomarkers of neurodegeneration in patients receiving Neurova therapy.
          Focus: tau pathology, neuroinflammation, and synaptic integrity
          markers. Enrollment: 64. Start: 2024-09-01. End: 2025-08-31.
        </p>
        <meta itemprop="identifier" content="TRIAL-NEUROVA-NEURO-BIO" />
        <meta itemprop="status" content="Recruiting" />
        <link
          itemprop="studySubject"
          href="https://bionova.example/id/drug/neurova"
        />
        <link
          itemprop="location"
          href="https://bionova.example/id/medical-org/central-neuroscience-institute"
        />
        <section>
          <h4>Principal Investigator</h4>
          <a
            itemprop="investigator"
            href="https://bionova.example/id/person/chiron"
            >Dr. Chiron</a
          >
        </section>
        <link
          itemprop="citation"
          href="https://bionova.example/id/policy/framework/ich-gcp-compliance"
        />
      </article>
    </section>

    <!-- Path Helper: Oncora Family Trial Progression -->
    <section
      itemscope
      itemtype="https://schema.org/CreativeWork"
      itemid="https://bionova.example/id/path/oncora-family-trial-progression"
    >
      <meta itemprop="name" content="Oncora Family Trial Progression" />
      <p itemprop="description">
        Oncora-XR Preclinical Release → Oncora Dose Optimization → Oncora Phase
        III
      </p>
      <link
        itemprop="about"
        href="https://bionova.example/id/trial/oncora-xr-preclinical-release"
      />
      <link
        itemprop="about"
        href="https://bionova.example/id/trial/oncora-dose-optimization"
      />
      <link
        itemprop="about"
        href="https://bionova.example/id/trial/oncora-phase-iii"
      />
    </section>
  </body>
</html>
